306 related articles for article (PubMed ID: 22676229)
1. Relation between smoking history and gene expression profiles in lung adenocarcinomas.
Staaf J; Jönsson G; Jönsson M; Karlsson A; Isaksson S; Salomonsson A; Pettersson HM; Soller M; Ewers SB; Johansson L; Jönsson P; Planck M
BMC Med Genomics; 2012 Jun; 5():22. PubMed ID: 22676229
[TBL] [Abstract][Full Text] [Related]
2. Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.
Karlsson A; Ringnér M; Lauss M; Botling J; Micke P; Planck M; Staaf J
Clin Cancer Res; 2014 Sep; 20(18):4912-24. PubMed ID: 25037737
[TBL] [Abstract][Full Text] [Related]
3. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J
Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450
[TBL] [Abstract][Full Text] [Related]
5. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.
Selamat SA; Chung BS; Girard L; Zhang W; Zhang Y; Campan M; Siegmund KD; Koss MN; Hagen JA; Lam WL; Lam S; Gazdar AF; Laird-Offringa IA
Genome Res; 2012 Jul; 22(7):1197-211. PubMed ID: 22613842
[TBL] [Abstract][Full Text] [Related]
6. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.
Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA
Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700
[TBL] [Abstract][Full Text] [Related]
7. Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas.
Paik PK; Johnson ML; D'Angelo SP; Sima CS; Ang D; Dogan S; Miller VA; Ladanyi M; Kris MG; Riely GJ
Cancer; 2012 Dec; 118(23):5840-7. PubMed ID: 22605530
[TBL] [Abstract][Full Text] [Related]
8. Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology.
Vucic EA; Thu KL; Pikor LA; Enfield KS; Yee J; English JC; MacAulay CE; Lam S; Jurisica I; Lam WL
BMC Cancer; 2014 Oct; 14():778. PubMed ID: 25342220
[TBL] [Abstract][Full Text] [Related]
9. Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival.
Guo NL; Wan YW
Artif Intell Med; 2012 Jun; 55(2):97-105. PubMed ID: 22326768
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in lung adenocarcinomas of smokers and nonsmokers.
Powell CA; Spira A; Derti A; DeLisi C; Liu G; Borczuk A; Busch S; Sahasrabudhe S; Chen Y; Sugarbaker D; Bueno R; Richards WG; Brody JS
Am J Respir Cell Mol Biol; 2003 Aug; 29(2):157-62. PubMed ID: 12600827
[TBL] [Abstract][Full Text] [Related]
11. Establishment and expression profiling of new lung cancer cell lines from Chinese smokers and lifetime never-smokers.
Lam DC; Girard L; Suen WS; Chung LP; Tin VP; Lam WK; Minna JD; Wong MP
J Thorac Oncol; 2006 Nov; 1(9):932-42. PubMed ID: 17409975
[TBL] [Abstract][Full Text] [Related]
12. Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer.
Boelens MC; van den Berg A; Fehrmann RS; Geerlings M; de Jong WK; te Meerman GJ; Sietsma H; Timens W; Postma DS; Groen HJ
J Pathol; 2009 Jun; 218(2):182-91. PubMed ID: 19334046
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq.
Beane J; Vick J; Schembri F; Anderlind C; Gower A; Campbell J; Luo L; Zhang XH; Xiao J; Alekseyev YO; Wang S; Levy S; Massion PP; Lenburg M; Spira A
Cancer Prev Res (Phila); 2011 Jun; 4(6):803-17. PubMed ID: 21636547
[TBL] [Abstract][Full Text] [Related]
14. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival.
Landi MT; Dracheva T; Rotunno M; Figueroa JD; Liu H; Dasgupta A; Mann FE; Fukuoka J; Hames M; Bergen AW; Murphy SE; Yang P; Pesatori AC; Consonni D; Bertazzi PA; Wacholder S; Shih JH; Caporaso NE; Jen J
PLoS One; 2008 Feb; 3(2):e1651. PubMed ID: 18297132
[TBL] [Abstract][Full Text] [Related]
15. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
Yuan P; Kadara H; Behrens C; Tang X; Woods D; Solis LM; Huang J; Spinola M; Dong W; Yin G; Fujimoto J; Kim E; Xie Y; Girard L; Moran C; Hong WK; Minna JD; Wistuba II
PLoS One; 2010 Feb; 5(2):e9112. PubMed ID: 20161759
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (
Lehrer S; Rheinstein PH
Cancer Genomics Proteomics; 2018; 15(5):387-393. PubMed ID: 30194079
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
Pulling LC; Divine KK; Klinge DM; Gilliland FD; Kang T; Schwartz AG; Bocklage TJ; Belinsky SA
Cancer Res; 2003 Aug; 63(16):4842-8. PubMed ID: 12941804
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 pathway dysregulation in the smoke-exposed airway epithelium and lung tumor tissue.
Beane J; Cheng L; Soldi R; Zhang X; Liu G; Anderlind C; Lenburg ME; Spira A; Bild AH
Cancer Res; 2012 Nov; 72(22):5702-11. PubMed ID: 22986747
[TBL] [Abstract][Full Text] [Related]
19. Smoking-induced CXCL14 expression in the human airway epithelium links chronic obstructive pulmonary disease to lung cancer.
Shaykhiev R; Sackrowitz R; Fukui T; Zuo WL; Chao IW; Strulovici-Barel Y; Downey RJ; Crystal RG
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):418-25. PubMed ID: 23597004
[TBL] [Abstract][Full Text] [Related]
20. K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung.
Westra WH; Slebos RJ; Offerhaus GJ; Goodman SN; Evers SG; Kensler TW; Askin FB; Rodenhuis S; Hruban RH
Cancer; 1993 Jul; 72(2):432-8. PubMed ID: 8319174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
